About GoodRx Holdings, Inc.
https://www.goodrx.comGoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.
CEO
Wendy Barnes
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 80
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
TD Cowen
Buy
JP Morgan
Overweight
Wells Fargo
Overweight
Morgan Stanley
Equal Weight
UBS
Neutral
Mizuho
Neutral
Grade Summary
Showing Top 6 of 8
Price Target
Institutional Ownership
FRANCISCO PARTNERS MANAGEMENT, LP
Shares:60.08M
Value:$165.22M
VANGUARD GROUP INC
Shares:9.21M
Value:$25.32M
AMERIPRISE FINANCIAL INC
Shares:3.89M
Value:$10.68M
Summary
Showing Top 3 of 186
About GoodRx Holdings, Inc.
https://www.goodrx.comGoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $196.03M ▼ | $167.99M ▲ | $1.12M ▼ | 0.57% ▼ | $0 ▼ | $36.05M ▼ |
| Q2-2025 | $203.07M ▲ | $142.28M ▼ | $12.84M ▲ | 6.32% ▲ | $0.04 ▲ | $50.03M ▲ |
| Q1-2025 | $202.97M ▲ | $166.23M ▼ | $11.05M ▲ | 5.45% ▲ | $0.03 ▲ | $48.22M ▲ |
| Q4-2024 | $198.58M ▲ | $168.21M ▲ | $6.74M ▼ | 3.39% ▼ | $0.02 ▼ | $41.86M ▲ |
| Q3-2024 | $195.25M | $163.16M | $12.26M | 6.28% | $0.03 | $38M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $273.53M ▼ | $1.33B ▲ | $724.79M ▲ | $600.71M ▼ |
| Q2-2025 | $281.32M ▼ | $1.32B ▲ | $675.67M ▲ | $643.03M ▼ |
| Q1-2025 | $300.98M ▼ | $1.3B ▼ | $640.92M ▼ | $654.35M ▼ |
| Q4-2024 | $448.35M ▲ | $1.39B ▲ | $663.41M ▲ | $724.66M ▲ |
| Q3-2024 | $423.78M | $1.35B | $658.41M | $696.43M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $1.12M ▼ | $76.02M ▲ | $-18M ▲ | $-65.81M ▼ | $-7.79M ▲ | $58.02M ▲ |
| Q2-2025 | $12.84M ▲ | $49.58M ▲ | $-18.32M ▲ | $-50.93M ▲ | $-19.66M ▲ | $31.27M ▲ |
| Q1-2025 | $11.05M ▲ | $9.41M ▼ | $-51.88M ▼ | $-104.9M ▼ | $-147.37M ▼ | $-12.46M ▼ |
| Q4-2024 | $6.74M ▲ | $44.74M ▼ | $-16.64M ▼ | $-3.53M ▲ | $24.57M ▲ | $28.1M ▼ |
| Q3-2024 | $3.96M | $86.86M | $-15.86M | $-172.13M | $-101.13M | $86.46M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Other Revenue | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
 Prescription Transactions Revenue | $290.00M ▲ | $150.00M ▼ | $140.00M ▼ | $130.00M ▼ |
 Subscription Revenue | $40.00M ▲ | $20.00M ▼ | $20.00M ▲ | $20.00M ▲ |
CEO
Wendy Barnes
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 80
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
TD Cowen
Buy
JP Morgan
Overweight
Wells Fargo
Overweight
Morgan Stanley
Equal Weight
UBS
Neutral
Mizuho
Neutral
Grade Summary
Showing Top 6 of 8
Price Target
Institutional Ownership
FRANCISCO PARTNERS MANAGEMENT, LP
Shares:60.08M
Value:$165.22M
VANGUARD GROUP INC
Shares:9.21M
Value:$25.32M
AMERIPRISE FINANCIAL INC
Shares:3.89M
Value:$10.68M
Summary
Showing Top 3 of 186